Nancy Kreis Newman

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.